<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Zhao YT</submitter><funding>NIDCR NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>Angiopoietin 1 and 2 (Ang1 and Ang2) modulate angiogenesis and vascular homeostasis through engagement of their very similar F-domain modules with the Tie2 receptor tyrosine kinase on endothelial cells. Despite this similarity in the underlying receptor binding interaction, the two angiopoietins have opposite effects: Ang1 induces phosphorylation of protein kinase B (AKT), strengthens cell-cell junctions and enhances endothelial cell survival while Ang2 antagonizes these effects &lt;sup>1-4&lt;/sup> . To investigate the molecular basis for the opposing effects, we examined the protein kinase activation and morphological phenotypes produced by a series of computationally designed protein scaffolds presenting the Ang1 F-domain in a wide range of valencies and geometries. We find two broad phenotyp</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2020.09.19.304188</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7836102</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>F-domain valency determines outcome of signaling through the angiopoietin pathway.</pubmed_title><pmcid>PMC7836102</pmcid><funding_grant_id>P01 GM081619</funding_grant_id><funding_grant_id>T90 DE021984</funding_grant_id><funding_grant_id>U01 HL099997</funding_grant_id><funding_grant_id>R01 GM097372</funding_grant_id><funding_grant_id>U01 HL099993</funding_grant_id><funding_grant_id>R01 GM083867</funding_grant_id><funding_grant_id>TL1 TR002318</funding_grant_id><pubmed_authors>Ruohola-Baker H</pubmed_authors><pubmed_authors>Somasundaram L</pubmed_authors><pubmed_authors>Xavier I</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Baker D</pubmed_authors><pubmed_authors>Fallas JA</pubmed_authors><pubmed_authors>Zhao YT</pubmed_authors><pubmed_authors>Saini S</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Sellers DL</pubmed_authors><pubmed_authors>Mathieu J</pubmed_authors><pubmed_authors>Wrenn S</pubmed_authors><pubmed_authors>Carter L</pubmed_authors><pubmed_authors>Ueda G</pubmed_authors><pubmed_authors>Ehnes D</pubmed_authors></additional><is_claimable>false</is_claimable><name>F-domain valency determines outcome of signaling through the angiopoietin pathway.</name><description>Angiopoietin 1 and 2 (Ang1 and Ang2) modulate angiogenesis and vascular homeostasis through engagement of their very similar F-domain modules with the Tie2 receptor tyrosine kinase on endothelial cells. Despite this similarity in the underlying receptor binding interaction, the two angiopoietins have opposite effects: Ang1 induces phosphorylation of protein kinase B (AKT), strengthens cell-cell junctions and enhances endothelial cell survival while Ang2 antagonizes these effects &lt;sup>1-4&lt;/sup> . To investigate the molecular basis for the opposing effects, we examined the protein kinase activation and morphological phenotypes produced by a series of computationally designed protein scaffolds presenting the Ang1 F-domain in a wide range of valencies and geometries. We find two broad phenotyp</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2026-04-07T22:14:54.645Z</modification><creation>2021-02-21T04:12:25Z</creation></dates><accession>S-EPMC7836102</accession><cross_references><pubmed>33501432</pubmed><doi>10.1101/2020.09.19.304188</doi></cross_references></HashMap>